Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$913K Sell
2,520
-36
-1% -$12.3K 0.2% 107
2026
Q1
$899K Buy
2,556
+20
+0.8% +$7.13K 0.2% 104
2025
Q4
$830K Sell
2,536
-864
-25% -$274K 0.18% 108
2025
Q3
$959K Sell
3,400
-38
-1% -$11K 0.22% 93
2025
Q2
$960K Sell
3,438
-754
-18% -$214K 0.23% 90
2025
Q1
$1.31M Sell
4,192
-54
-1% -$15.9K 0.32% 71
2024
Q4
$1.11M Buy
4,246
+27
+0.6% +$8.01K 0.27% 80
2024
Q3
$1.36M Buy
4,219
+160
+4% +$52.3K 0.34% 68
2024
Q2
$1.27M Sell
4,059
-334
-8% -$98.1K 0.34% 71
2024
Q1
$1.27M Hold
4,393
0.37% 63
2023
Q4
$1.27M Sell
4,393
-189
-4% -$51.5K 0.37% 63
2023
Q3
$1.23M Buy
4,582
+59
+1% +$14.7K 0.42% 56
2023
Q2
$1M Buy
4,523
+160
+4% +$37.1K 0.34% 70
2023
Q1
$1.05M Sell
4,363
-35
-0.8% -$8.59K 0.37% 64
2022
Q4
$1.16M Buy
4,398
+280
+7% +$75.1K 0.41% 61
2022
Q3
$928K Buy
4,118
+35
+0.9% +$8.48K 0.37% 68
2022
Q2
$993K Sell
4,083
-110
-3% -$27K 0.38% 66
2022
Q1
$1.01M Buy
4,193
+14
+0.3% +$3.22K 0.34% 74
2021
Q4
$940K Buy
4,179
+68
+2% +$14.4K 0.32% 81
2021
Q3
$927K Sell
4,111
-37
-0.9% -$8.52K 0.34% 83
2021
Q2
$987K Buy
4,148
+149
+4% +$36.7K 0.38% 72
2021
Q1
$899K Buy
3,999
+160
+4% +$38.2K 0.39% 68
2020
Q4
$883K Sell
3,839
-60
-2% -$13.8K 0.39% 66
2020
Q3
$991K Buy
3,899
+69
+2% +$17.1K 0.49% 54
2020
Q2
$903K Buy
3,830
+46
+1% +$10.5K 0.54% 48
2020
Q1
$767K Sell
3,784
-203
-5% -$44.3K 0.55% 49
2019
Q4
$962K Sell
3,987
-175
-4% -$38.6K 0.49% 56
2019
Q3
$805K Sell
4,162
-2,590
-38% -$497K 0.43% 60
2019
Q2
$1.25M Buy
6,752
+3,606
+115% +$646K 0.44% 54
2019
Q1
$598K Buy
3,146
+150
+5% +$28.6K 0.34% 68
2018
Q4
$583K Buy
+2,996
New +$584K 0.37% 67

Other funds holding AMGN

Essex Savings Bank's AMGN Position: Q2 2026 in Review

Essex Savings Bank reduced its Amgen (AMGN) stake by 1.4% in Q2 2026, selling an estimated $12.3K and leaving 2,520 shares worth $913K. The position accounts for 0.2% of the portfolio, ranked #107.

Essex Savings Bank first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.36M in Q3 2024. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Essex Savings Bank held 2,520 shares of Amgen worth $913K as of Q2 2026.
  • Essex Savings Bank sold 36 Amgen shares in Q2 2026, an estimated $12.3K.
  • Amgen made up 0.2% of Essex Savings Bank's portfolio in Q2 2026, its #107 holding.
  • Essex Savings Bank first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
  • Essex Savings Bank's Amgen position peaked at $1.36M in Q3 2024.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Essex Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.